Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study

Acute myeloid leukemia (AML) with t(6;9)(p22;q34) is a distinct entity accounting for 1-2% of AML cases. A substantial proportion of these patients have a concomitant FLT3-ITD. While outcomes are dismal with intensive chemotherapy, limited evidence suggests allogeneic hematopoietic cell transplantat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kayser, Sabine, Hills, Robert K., Luskin, Marlise R., Brunner, Andrew M., Terré, Christine, Westermann, Jörg, Menghrajani, Kamal, Shaw, Carole, Baer, Maria R., Elliott, Michelle A., Perl, Alexander E., Ráčil, Zdeněk, Mayer, Jiri, Zak, Pavel, Szotkowski, Tomas, de Botton, Stéphane, Grimwade, David, Mayer, Karin, Walter, Roland B., Krämer, Alwin, Burnett, Alan K., Ho, Anthony D., Platzbecker, Uwe, Thiede, Christian, Ehninger, Gerhard, Stone, Richard M., Röllig, Christoph, Tallman, Martin S., Estey, Elihu H., Müller-Tidow, Carsten, Russell, Nigel H., Schlenk, Richard F., Levis, Mark J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939530/
https://www.ncbi.nlm.nih.gov/pubmed/31004014
http://dx.doi.org/10.3324/haematol.2018.208678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939530/
https://www.ncbi.nlm.nih.gov/pubmed/31004014
http://dx.doi.org/10.3324/haematol.2018.208678

Ejemplares similares